Teng‐Kuang Yeh

National Health Research Institutes — Taiwan

Medicine · Health Sciences

30h-index3.3kcitations155works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(29), Protein Degradation and Inhibitors(27), Chromatin Remodeling and Cancer(20), Diabetes Treatment and Management(11), Lung Cancer Treatments and Mutations(10)

Publications154 total

<i>In vitro</i> and <i>in vivo</i> efficacy of vancomycin against <i>Elizabethkingia</i> species and the impact of increased vancomycin MICs
Microbiology Spectrum·2025· 1 citedOpen Access
Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix
Journal of Medicinal Chemistry·2025· 1 citedOpen Access
Monitoring Leg Muscle Strength Symmetry via Electromyography
2025Open Access
Design, preparation, and characterization of injectable thermosensitive polymer-based hydrogels with enhanced mechanical properties for sustained liraglutide release
Journal of Drug Delivery Science and Technology·2025
Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid
Journal of Medicinal Chemistry·2025· 10 citedOpen Access
Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies
Journal of Medicinal Chemistry·2025· 3 citedOpen Access
IgG-4 Sclerosing Pancreatitis in Pancreas
2025
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization
Journal of Medicinal Chemistry·2024· 7 citedOpen Access
iPSC-Derived CAR-Gamma Delta T with Novel Combinatorial KO Demonstrated Extended Longevity and Profound Anti-Tumor Efficacy without Cytokine Support in Preclinical Studies
Blood·2024· 2 citedOpen Access
Discovery of the Unique GMP-Grade iPSC Clones That Give Rise to Functional, High Purity, Matured CD8 Alpha Beta T or Gamma Delta T with Exponential Expansion Capacity
Blood·2024
DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral Administration
Journal of Medicinal Chemistry·2024· 2 cited
Development of an orally bioavailable covalent STING inhibitor
2024
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia
Cell chemical biology·2024· 3 cited
Development of a Humanized Antibody Targeting Extracellular HSP90α to Suppress Endothelial-Mesenchymal Transition-Enhanced Tumor Growth of Pancreatic Adenocarcinoma Cells
Cells·2024· 3 citedOpen Access
Supplementary Figure S8 from Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus
2024Open Access
Supplementary Figure S7 from Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus
2024Open Access
Supplementary Figure S1 from Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus
2024Open Access
Supplementary Materials and Methods from Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus
2024Open Access
Supplementary Table S1 from Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus
2024Open Access
Supplementary Figure S3 from Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus
2024Open Access
page 1 of 8Next →

Frequent Co-authors

Yu‐Sheng Chao(16), Jen‐Shin Song(16), Chiung‐Tong Chen(14), Hsien‐Tsung Yao(9), Kak‐Shan Shia(7), Pinpin Lin(6), Hsing‐Pang Hsieh(6), Yi-Wei Chang(6), Yi‐Yu Ke(6), Ming‐Shiu Hung(6), Ming‐Hsien Tsai(5), Jessie L.‐S. Au(5), Weir‐Torn Jiaang(5), Chien-Huang Wu(5), Chuan Shih(5), Szu‐Huei Wu(5), Chung-Yu Huang(5), Min‐Hsien Wang(5), Chun‐Ping Chang(5), Louis W. Chang(4)